Navigation Links
Isis Reports Financial Results and Highlights for Third Quarter 2010
Date:11/4/2010

-cash stock compensation.  Please refer to the reconciliation of pro forma and GAAP measures, which is explained later in this release.

RevenueRevenue for the three and nine months ended September 30, 2010 was $28.6 million and $82.1 million, respectively, compared to $26.8 million and $89.3 million for the same periods in 2009.  Isis' revenue fluctuates based on the nature and timing of payments under agreements with the Company's partners, including license fees, milestone-related payments and other payments.  Isis recognized new revenue in the first nine months of 2010 in the form of an upfront fee from the Company's new partnership with GlaxoSmithKline (GSK), which is amortized through the first quarter of 2015, milestone payments from GSK, Bristol-Myers Squibb and Achaogen and sublicensing income from Regulus' collaboration with sanofi-aventis.  Although Isis recognized this new revenue, its revenue for 2010 decreased compared to 2009 because the amortization of the upfront fee from the Company's Ortho-McNeil collaboration ended in the third quarter of 2009. Additionally, revenue for the first nine months of 2010 decreased by $2.4 million because Isis is no longer including Regulus' revenue in its 2010 revenue.  

Operating ExpensesOn a pro forma basis, operating expenses for the three and nine months ended September 30, 2010 were $34.6 million and $105.1 million, respectively, compared to $33.6 million and $95.4 million for the same periods in 2009.  The higher expenses in 2010 were primarily due to an increase in costs associated with advancing mipomersen toward its initial regulatory filings for marketing approval planned for the first half of next year and offset in part by an $8.3 million decrease because Isis is no longer including Regulus' operating expenses in its 2010 operating expenses.  On a GAAP basis, Isis' operating expenses from continuing operations for the three and nine m
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013  Boehringer Ingelheim will contribute to advancing ... American Thoracic Society International Conference (ATS 2013) in ... – 22. Data will highlight research ... of chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® ... compounds for asthma, idiopathic pulmonary fibrosis (IPF) and ...
(Date:5/17/2013)... 2013 Oramed Pharmaceuticals Inc. (NASDAQCM: ... delivery systems, announced today that the United States Food ... New Drug application(IND) for ORMD-0801, its oral insulin capsule. ... FDA clearance to proceed," stated Nadav Kidron ... a major milestone for Oramed and we look forward ...
(Date:5/16/2013)... CHICAGO, Ill. and MECHELEN, Belgium ... (Euronext: GLPG) and AbbVie (NYSE: ABBV ) ... collaboration to include Crohn,s disease.  Galapagos will fund and ... is designed to facilitate rapid progression into Phase 3.  ... 2015, AbbVie will pay Galapagos $50 million.  The terms ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... couples to create page on Pinktimeline.com to receive £50 ... have launched a fundraising resource on their website, http://www.pinktimeline.com ... for associated costs. Couples can create a private fundraising page ... raise funds for specialty consultations, fertility treatments or even to ...
... 25, 2011 INNOPHARMA LLC announced today FDA approval of ... generic equivalent of Zyprexa® injection). As the developer ... with Sandoz Inc., pursuant to which Sandoz will sell, market ... About INNOPHARMA: INNOPHARMA is ...
Cached Medicine Technology:First Response Launches IVF Fundraising Resource for Those Trying for a Baby 2First Response Launches IVF Fundraising Resource for Those Trying for a Baby 3
(Date:5/18/2013)... (May 18, 2013) A ground-breaking advance in ... according to research presented today at Digestive Disease ... minimal withdrawal time for colonoscopies and exploring safer ... colonoscopy, doctors use a device called a colonoscope ... colorectal cancer allows a doctor to look for ...
(Date:5/18/2013)... York (PRWEB) May 18, 2013 ... mesh products continue to move forward in a consolidated ... Bernstein Liebhard LLP reports. According to a notice on ... the Ethicon pelvic mesh litigation will be held on ... complaints have been filed in the proceeding on behalf ...
(Date:5/18/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) -- It ... but new research shows that college women are more likely ... than are college men. Much of this difference ... on a weekly basis is much lower for women than ... for men. But, there,s good reason for that difference. Women ...
(Date:5/18/2013)... After working diligently for months and putting in a ... integration of the fitment specs for the redesigned 2012 Hyundai ... the automobile market with its extraordinary features and unique combination ... the latest entry in the size it up ... year 2013. , Aptly suiting its name, 2012 Hyundai ...
(Date:5/18/2013)... DC (PRWEB) May 18, 2013 Family Magazine ... designation for excellence by Follow Media Consulting, Inc. in the ... signifies the continued commitment and dedication of the areas best ... , No one knows parenting better than Brenda Hyde, a ... is to help parents know about the vast resources available ...
Breaking Medicine News(10 mins):Health News:New colonoscope provides ground-breaking view of colon 2Health News:New colonoscope provides ground-breaking view of colon 3Health News:New colonoscope provides ground-breaking view of colon 4Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:College Women More Prone to Problem Drinking Than Men: Study 2Health News:College Women More Prone to Problem Drinking Than Men: Study 3Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2
... -- Alcohol use by American teens has dropped to historic ... believe it,s a dangerous drug, according to an annual national ... and the University of Michigan. The nationally representative survey ... 400 public and private schools found a continuing trend of ...
... GURGAON, Delhi (NCR), India -- Vishwa Mohan Katoch, M.D., ... India: Future Directions" at the AACR International Conference on ... Therapy, Dec. 13-16, 2011, in Gurgaon, Delhi (NCR), India. ... India Department of Health Research and director-general of the ...
... cancers worldwide. Kaposi,s sarcoma herpesvirus (KSHV) is an etiological ... lymphoproliferative malignancies. KS is the most common cancer in ... cancer deaths in many subequatorial African countries as a ... of Biotechnology and Research Programs Unit (Genome-Scale Biology) at ...
... and the Management Sciences (INFORMS) today announced the award ... Medal to Dr. Don N. Kleinmuntz, President and co-founder ... web-based financial analytics and performance management software tools used ... their financial planning, budgeting, and reporting processes. , ...
... News) --,A new study finds that two out of ... hands. Researchers gave seven scenarios to 85 third-year ... asked them to identify which of the situations required ... correctly identified the five scenarios that required hand hygiene: ...
... conducted by researchers at Boston University School of Medicine ... house dust extract (HDE) causes pulmonary inflammation that aggravates ... PhD, professor of pathology, was published in the December ... and was selected by the editorial board as the ...
Cached Medicine News:Health News:Alcohol Use Down, Pot Use Up Among U.S. Teens 2Health News:KS-herpesvirus induces reprogramming of lymphatic endothelial cells to invasive mesenchymal cells 2Health News:INFORMS presents Ramsey Medal to health care financial analytics executive Don Kleinmuntz 2
... objective and high power negative lens delivering ... true benefit of this system is ease ... is made possible due to a superior ... bar and individual interpupillary adjustment provides stability ...
... 23 gauge thin wall irrigation. 25 ... degree shaft 10 mm from tip ... mm behind aspiration tip. Side taper ... (18.1 inches) of silicone tubing (N5941 ...
... with five legs for extra stability. Adjustable ... vertical travel 6"). 2" ball bearing swivel ... retardant upholstery, available in black vinyl as ... Top of the range pneumatic stool with ...
Lacrimal Cannulas, 26 g. curved. Overall length 29 mm. 5/box....
Medicine Products: